HTG Molecular Diagnostics' Series D - II Round

HTG Molecular Diagnostics raised a round of funding on November 15, 2012.

HTG Molecular Diagnostics provides simple, cost effective solutions for accurate RNA testing. In 2013 the company commercialized its Edge instrument platform and a portfolio of mRNA assays that levera…

Articles about HTG Molecular Diagnostics' Series D - II Round: